Aspen in best position in 10 years with CEO Stephen Saad at the helm

Aspen Pharmacare has been through a difficult phase of restructuring but the pharmaceutical giant is in great shape, especially with the latest sale of its thrombosis unit to Mylan. With Covid-19 wreaking havoc, Aspen is also in a great position with the production and distribution of the life-saving drug Dexamethasone. BizNews founder Alec Hogg was joined by CEO Stephen Saad during his Rational Radio webinar to discuss Aspen's excellent preliminary results as well as his desire to take Aspen further into vaccine territory. Market commentator David Shapiro and Adrian Saville of Cannon Asset Managers also joined the fascinating discussion. Learn more about your ad choices. Visit megaphone.fm/adchoices